Logo image of BMY

BRISTOL-MYERS SQUIBB CO (BMY) Stock Overview

NYSE:BMY - US1101221083 - Common Stock

47.14 USD
-0.78 (-1.63%)
Last: 8/25/2025, 8:06:46 PM
47.18 USD
+0.04 (+0.08%)
After Hours: 8/25/2025, 8:06:46 PM

BMY Key Statistics, Chart & Performance

Key Statistics
52 Week High63.33
52 Week Low42.96
Market Cap95.95B
Shares2.04B
Float2.03B
Yearly Dividend2.42
Dividend Yield5.12%
EPS(TTM)6.73
PE7
Fwd PE7.76
Earnings (Next)10-30 2025-10-30/bmo
IPO07-05 1929-07-05
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


BMY short term performance overview.The bars show the price performance of BMY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20

BMY long term performance overview.The bars show the price performance of BMY in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of BMY is 47.14 USD. In the past month the price decreased by -0.78%. In the past year, price decreased by -5.63%.

BRISTOL-MYERS SQUIBB CO / BMY Daily stock chart

BMY Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 43.05 658.10B
JNJ JOHNSON & JOHNSON 17.84 429.67B
NVO NOVO-NORDISK A/S-SPONS ADR 14.41 250.34B
AZN ASTRAZENECA PLC-SPONS ADR 17.94 246.98B
NVS NOVARTIS AG-SPONSORED ADR 14.13 242.06B
MRK MERCK & CO. INC. 11.08 213.09B
PFE PFIZER INC 7.42 142.93B
SNY SANOFI-ADR 11.29 122.26B
GSK GSK PLC-SPON ADR 8.75 79.91B
ZTS ZOETIS INC 24.95 68.78B
TAK TAKEDA PHARMACEUTIC-SP ADR 50.23 47.59B
HLN HALEON PLC-ADR 19.76 43.43B

About BMY

Company Profile

BMY logo image Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 34,100 full-time employees. The company is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its platforms comprise chemically synthesized or small molecule drugs, including protein degraders; drugs produced from biological processes, called biologics; ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are also used. Biologics are typically administered through injections or by intravenous infusion. CAR-T cell therapies are administered by intravenous infusion. Its growth portfolio includes Opdivo, Opdivo Qvantig, Orencia, Yervoy, Reblozyl, Opdualag, and others. Its legacy portfolio includes Eliquis, Revlimid, Pomalyst/Imnovid, Sprycel and Abraxane.

Company Info

BRISTOL-MYERS SQUIBB CO

Route 206 And Province Line Road

Princeton NEW JERSEY 10016 US

CEO: Giovanni Caforio

Employees: 34100

BMY Company Website

BMY Investor Relations

Phone: 16092524621

BRISTOL-MYERS SQUIBB CO / BMY FAQ

What is the stock price of BRISTOL-MYERS SQUIBB CO today?

The current stock price of BMY is 47.14 USD. The price decreased by -1.63% in the last trading session.


What is the ticker symbol for BRISTOL-MYERS SQUIBB CO stock?

The exchange symbol of BRISTOL-MYERS SQUIBB CO is BMY and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is BMY stock listed?

BMY stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for BRISTOL-MYERS SQUIBB CO stock?

32 analysts have analysed BMY and the average price target is 52.54 USD. This implies a price increase of 11.45% is expected in the next year compared to the current price of 47.14. Check the BRISTOL-MYERS SQUIBB CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BRISTOL-MYERS SQUIBB CO worth?

BRISTOL-MYERS SQUIBB CO (BMY) has a market capitalization of 95.95B USD. This makes BMY a Large Cap stock.


How many employees does BRISTOL-MYERS SQUIBB CO have?

BRISTOL-MYERS SQUIBB CO (BMY) currently has 34100 employees.


What are the support and resistance levels for BRISTOL-MYERS SQUIBB CO (BMY) stock?

BRISTOL-MYERS SQUIBB CO (BMY) has a support level at 44.56 and a resistance level at 47.68. Check the full technical report for a detailed analysis of BMY support and resistance levels.


Is BRISTOL-MYERS SQUIBB CO (BMY) expected to grow?

The Revenue of BRISTOL-MYERS SQUIBB CO (BMY) is expected to decline by -1.27% in the next year. Check the estimates tab for more information on the BMY EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BRISTOL-MYERS SQUIBB CO (BMY) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BRISTOL-MYERS SQUIBB CO (BMY) stock pay dividends?

BRISTOL-MYERS SQUIBB CO (BMY) has a dividend yield of 5.12%. The yearly dividend amount is currently 2.42. Check the full fundamental report for a detailed analysis of BMY dividend history, reliability and sustainability.


When does BRISTOL-MYERS SQUIBB CO (BMY) report earnings?

BRISTOL-MYERS SQUIBB CO (BMY) will report earnings on 2025-10-30, before the market open.


What is the Price/Earnings (PE) ratio of BRISTOL-MYERS SQUIBB CO (BMY)?

The PE ratio for BRISTOL-MYERS SQUIBB CO (BMY) is 7. This is based on the reported non-GAAP earnings per share of 6.73 and the current share price of 47.14 USD. Check the full fundamental report for a full analysis of the valuation metrics for BMY.


What is the Short Interest ratio of BRISTOL-MYERS SQUIBB CO (BMY) stock?

The outstanding short interest for BRISTOL-MYERS SQUIBB CO (BMY) is 1.52% of its float. Check the ownership tab for more information on the BMY short interest.


BMY Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BMY Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BMY. While BMY has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BMY Financial Highlights

Over the last trailing twelve months BMY reported a non-GAAP Earnings per Share(EPS) of 6.73. The EPS increased by 391.24% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.58%
ROA 5.33%
ROE 28.96%
Debt/Equity 2.56
Chartmill High Growth Momentum
EPS Q2Q%-29.47%
Sales Q2Q%0.56%
EPS 1Y (TTM)391.24%
Revenue 1Y (TTM)2.57%

BMY Forecast & Estimates

32 analysts have analysed BMY and the average price target is 52.54 USD. This implies a price increase of 11.45% is expected in the next year compared to the current price of 47.14.

For the next year, analysts expect an EPS growth of 477.2% and a revenue growth -1.27% for BMY


Analysts
Analysts67.5
Price Target52.54 (11.46%)
EPS Next Y477.2%
Revenue Next Year-1.27%

BMY Ownership

Ownership
Inst Owners84.14%
Ins Owners0.03%
Short Float %1.52%
Short Ratio2.34